Tuesday, August 21, 2007

Mirabilis Adds $10.5M In Series A Extension

Seattle-based Mirabilis Medica, a firm developing medical products based on real-time ultrasound imaging, said Tuesday morning that it has raised $10.5M in a Series A extension. The financing was led by Arboretum Ventures, and also included Split Rock Partners, Dow Venture Capital, and an undisclosed individual investor. Mirabilis said the funding will go towards continued development and testing of its products. Mirabilis is developing products for treatment of uterine fibroids. More information »